Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types

OBJECTIVE: DNA damage response (DDR) genes have low mutation rates, which may restrict their clinical applications in predicting the outcomes of immune checkpoint inhibitor (ICI) treatment. Thus, a systemic analysis of multiple DDR genes is needed to identify potential biomarkers of ICI efficacy. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Zhe, Yang, Yue, Zhang, Jieyun, Guo, Weijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610155/
https://www.ncbi.nlm.nih.gov/pubmed/33960179
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610155/
https://www.ncbi.nlm.nih.gov/pubmed/33960179
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0351

Ejemplares similares